z-logo
open-access-imgOpen Access
Polymorphisms in microRNA let-7 binding sites of the HIF1AN and CLDN12 genes can predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
Author(s) -
Yueyao Du,
Liheng Zhou,
Yanping Lin,
Kai Yin,
Wenjin Yin,
Jinsong Lu
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.04.26
Subject(s) - taxane , breast cancer , single nucleotide polymorphism , oncology , odds ratio , medicine , genotype , biology , docetaxel , anthracycline , chemotherapy , cancer , cancer research , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom